Research & Development: Page 40
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Trending Now… As we head into the second half of the year (as hard to believe as that is) this is a great time to hit pause and evaluate what’s coming down the pike. In this issue, in particular, we are looking at a couple of areas that will have a lasting impact on the industry. First, this mont...
By Taren Grom • June 1, 2019 -
PharmaVoice Team/PharmaVoice
Upfront
Merck Debuts Documentary A Touch of Sugar Merck’s documentary film, A Touch of Sugar, debuted during the Tribeca Film Festival in April as a part of the company’s America’s Diabetes Challenge: Get to Your Goals. Narrated by award-winning actress and documentary spokesperson Viola Davis, the film ...
By PharmaVoice Team • June 1, 2019 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Colon Cancer Screening without the Prep Alex Ovadia, CEO of Check-Cap, talks about the company’s ingestible imaging capsule-based system for colorectal cancer screening. Colorectal cancer (CRC) — the term referring to both rectal and colon cancers — is the third most common cancer diagnosed in bo...
By Alex Ovadia • June 1, 2019 -
PharmaVoice Team/PharmaVoice
HealthTech
A Mobile Game That Can Detect Alzheimer’s Risk Trend Watch: From Games to Wrist Bands to at Home Diagnostic Tests, Healthtech Applications Expand Personalized Treatment or Therapy A specially designed mobile phone game can detect people at risk of Alzheimer’s, according to research from the Univ...
By PharmaVoice Team • June 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
IBM to use ML and AI to Diagnose Alzheimer’s Trend Watch: From drug development to diagnoses, pharma uses AI across the spectrum IBM has discontinued the development and sales of its Watson for drug discovery product due to poor financial performance, however, it will continue to serve pharmaceut...
By PharmaVoice Team • June 1, 2019 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Inspiring Leaders For the past 15 years or so, PharmaVOICE has had the honor of showcasing the Healthcare Businesswomen’s Association’s Rising Stars and more recently the Luminaries as well. These women have been identified by their organizations — which span the breadth of the healthcare ecosyst...
By Taren Grom • May 1, 2019 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Plants as Anti-infectives Alexander Huang, President and Chairman of Quellthera, talks about the company’s research on biomimicry of plant immune processes as potential therapeutics for hard-to-treat infections. Infections caused by antibiotic-resistant germs are difficult, and may soon become im...
By Alexander Huang • May 1, 2019 -
PharmaVoice Team/PharmaVoice
HealthTech
Alexa Goes HIPAA Trend Watch: HIPAA-Compliant Voice Assistants and Clinical Applications An invite-only program from Amazon allows select healthcare groups, including hospitals and health insurers, to develop HIPAA-compliant skills for its voice assistant Alexa. The big change is that Alexa can n...
By PharmaVoice Team • May 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
AI-Driven twoXAR and Ono Pharma Collaborate on Drug Discovery Research Trend Watch: Partnerships and Collaborations Advance AI Capabilities Ono Pharmaceutical, a Japanese pharmaceutical research and development company, and twoXAR Inc., an AI-driven biopharmaceutical company, have teamed up to jo...
By PharmaVoice Team • May 1, 2019 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Connected Health: An Important Tool for Improving Outcomes
The digital age has put more data and insights into the hands of healthcare professionals and patients. Digital technologies — wireless, electronic, mobile, telehealth — have made connected health possible, with the objective of enhancing patient engagement and ultimately health outcomes. To dete...
By PharmaVoice Team • May 1, 2019 -
PharmaVoice Team/PharmaVoice
Connected Health — We Could Learn From Marvel Studios
Marvel Studios is about to release its last Avengers movie. It brings together the biggest superheroes from a myriad of universes for the final epic battle, connecting many storylines for one last big hit. Marvel has done quite a bit over the last 10 years to connect these superhero worlds, throu...
By Angelo Joseph Campano • May 1, 2019 -
PharmaVoice Team/PharmaVoice
HBA Special Feature: The Power of the Network
The Healthcare Businesswomen’s Association has one of the most influential networks in the industry. The organization has been successful in building powerful communities, including its Rising Star and Luminary honorees, as well as being a valued consultant to many of its corporate partners to gu...
By PharmaVoice Team • May 1, 2019 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Hackathons and Innovation Hackathons have come a long way since the first reported use of the term back in 1999 when a group of developers came together in Calgary to avoid legal problems due to export regulations of cryptographic software from the United States. Today, hackathons, hackfests, and...
By Taren Grom • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Upfront
Let’s talk About Mental Health In Men Otsuka has launched an original video series entitled “Let’s Talk! We’re Better Together" to encourage conversations about mental wellness. Social stigma is an intimidating reality for many people suffering with mental illness, so the last thing one may think...
By PharmaVoice Team • March 1, 2019 -
PharmaVoice Team/PharmaVoice
HealthTech
The World’s First Virtual Caregiver Unveiled Trend Watch: Meeting Patient Needs Through Technology SameDay Security, a provider of automated home care solutions and safety devices, unveiled the world’s first virtual caregiver, Addison Care, earlier this year at the annual Computer Electronic Show...
By PharmaVoice Team • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Genpact Research: AI Adoption Accelerating Trend Watch: AI Applications Grow Across the Healthcare Spectrum The adoption of AI is rapidly growing, however, to take full advantage of AI’s opportunities, businesses must understand and overcome lingering doubts from their customers and employees, ac...
By PharmaVoice Team • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Restoring the Microbiome Todd Krueger, President and CEO of AOBiome Therapeutics, discusses the company’s research to develop therapies that aim to re-introduce beneficial bacteria to the microbiome. The human microbiome consists of trillions of microorganisms that live in and on humans and are e...
By Todd Krueger • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Last Word
Connecting Rare Disease Patients Angie Rowe, Interim Executive Director, Global Genes, talks about the 10th anniversary of the rare disease organization and its vision for the future. PV: Over the past 10 years, what impact has Global Genes had on the rare disease community? Rowe: When Nicole Boi...
By Angie Rowe • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Hacking the Biopharma Industry
Biopharmaceutical companies and their partners are taking a page from Silicon Valley by sponsoring hackathons and competitions to drive innovation in research and develop new solutions for patients. Pharma companies are reaching outside their own walls to discover innovative new ways to improve t...
By Denise Myshko • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Wearables In Clinical Trials
Wearables are improving the clinical trial experience for patients and satisfying the need to collect data for real-world use studies. Experts agree: future drug development will be based on broader, real-time patient data. Connected health, which includes wearable devices and mobile health (mHea...
By Denise Myshko • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Red Zone: Innovation from the Inside Out
In November 2018, Cognizant was proud to introduce two new products into the Life Sciences market. Both came out of our Accelerator LaunchPad program, which solicits ideas, creates internal startups, and launches only those products that can survive and thrive throughout its rigorous process. But...
By Ari Srinivasan • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Agile Transformation By definition change is hard, and anyone who works for a large or even a small company has been through at least one reorganization. The agility that companies will need to compete in the new economy, one defined by the digitization of healthcare, cannot be underestimated, an...
By Taren Grom • Feb. 1, 2019 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Harnessing the Power of the Body’s Electrical System Frank Amato, CEO of electroCore, talks about how vagus nerve stimulation can be used for the preventive treatment of cluster headache and for the relief of pain associated with migraine and episodic cluster headache. Our nervous system interact...
By Frank Amato • Feb. 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Bayer Uses AI to Boost Pharmacovigilance Trend Watch: Pharma Use of AI Increases In an effort to accelerate its patient safety data monitoring by using artificial intelligence, Bayer has partnered with Genpact to employ its Pharmacovigilance Artificial Intelligence (PVAI) products. These AI tools...
By PharmaVoice Team • Feb. 1, 2019 -
PharmaVoice Team/PharmaVoice
Transformation: Ready, Set, Agile
According to McKinsey, companies that have enterprise agility share some commonalities: a North Star-mentality, in other words an overarching customer strategy; a scalable team structure; a rapid decision-making mentality; a dynamic people model that ignites passion; and a willing adoption of nex...
By PharmaVoice Team • Feb. 1, 2019
Previous
